Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Metastases to lung
ADR ID BADD_A02760
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.22      Metastases
16.22.02      Metastases to specified sites
16.22.02.002      Metastases to lung
22      Respiratory, thoracic and mediastinal disorders
22.08      Respiratory tract neoplasms
22.08.01      Lower respiratory tract neoplasms
22.08.01.005      Metastases to lung
Description Not Available
MedDRA Code 10027458
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Endobronchial metastases | Lung metastases | Lung secondaries | Metastases to lung | Metastasis in lung | Pulmonary metastases | Pulmonary secondaries | Secondary malignant neoplasm of lung
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01248Lapatinib0.000448%
BADD_D01254Lenvatinib0.000224%
BADD_D01257Letrozole0.004346%
BADD_D01258Leucovorin0.002478%
BADD_D01260Leuprolide acetate0.007170%
BADD_D01378Memantine0.000181%
BADD_D01567Nilotinib0.000448%
BADD_D01572Nitisinone0.006469%
BADD_D01601Olaparib0.000560%
BADD_D01629Osimertinib0.001287%
BADD_D01633Oxaliplatin0.000672%
BADD_D01653Paclitaxel0.000504%
BADD_D01687Pazopanib0.003078%
BADD_D01777Pioglitazone0.000129%
BADD_D01817Pramipexole--
BADD_D01818Pramipexole dihydrochloride--
BADD_D01909Ramipril0.000140%
BADD_D01922Regorafenib0.007163%
BADD_D02029Sitagliptin0.000478%
BADD_D02058Sorafenib0.005820%
BADD_D02105Tacrolimus0.001782%
BADD_D02106Tadalafil0.000195%
BADD_D02150Temozolomide0.000224%
BADD_D02257Trametinib0.000414%
BADD_D02344Vemurafenib0.000392%
BADD_D02365Vismodegib0.000280%
BADD_D02375Water--
BADD_D02392Zoledronic acid--
BADD_D02407Upadacitinib0.000530%
BADD_D02412Octreotide--
The 2th Page    First    Pre   2 3    Next   Last    Total 3 Pages